News and Announcements

Haleon reaffirms outlook despite weaker-than-expected Q1 sales

By Abigail Townsend

Date: Wednesday 29 Apr 2026

(Sharecast News) - Panadol-owner Haleon reiterated full-year guidance on Wednesday, despite a poor cold and flu season weighing on first quarter sales.
The consumer healthcare giant - which also owns Sensodyne, Centrum and Voltaren, among others - saw revenues edge up 0.1% in the three months to 31 March, or by...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page